Global Antiviral Drug Resistance Market Growth (Status and Outlook) 2022-2028
- LP 4882628
- 100 Pages
- March 2022
- Medical Devices
The United States Antiviral Drug Resistance market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Antiviral Drug Resistance market, reaching US$ million by the year 2028. As for the Europe Antiviral Drug Resistance landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Antiviral Drug Resistance players cover AccuBioTech Co., Ltd., ACON Laboratories, Inc., Siemens AG, and BioMerieux SA, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Antiviral Drug Resistance market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Sanger Sequencing
Other Technologies
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals & Clinics
Pathology or Diagnostic Laboratories
Research Institutes
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AccuBioTech Co., Ltd.
ACON Laboratories, Inc.
Siemens AG
BioMerieux SA
Bio-Rad Laboratories, Inc.
Danaher
Abbott
BD
F. Hoffmann-La Roche Ltd.
Trinity Biotech
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antiviral Drug Resistance Market Size 2017-2028
2.1.2 Antiviral Drug Resistance Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Antiviral Drug Resistance Segment by Type
2.2.1 Immunodiagnostics
2.2.2 Polymerase Chain Reaction (PCR)
2.2.3 Next Generation Sequencing (NGS)
2.2.4 Sanger Sequencing
2.2.5 Other Technologies
2.3 Antiviral Drug Resistance Market Size by Type
2.3.1 Antiviral Drug Resistance Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Antiviral Drug Resistance Market Size Market Share by Type (2017-2022)
2.4 Antiviral Drug Resistance Segment by Application
2.4.1 Hospitals & Clinics
2.4.2 Pathology or Diagnostic Laboratories
2.4.3 Research Institutes
2.4.4 Others
2.5 Antiviral Drug Resistance Market Size by Application
2.5.1 Antiviral Drug Resistance Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Antiviral Drug Resistance Market Size Market Share by Application (2017-2022)
3 Antiviral Drug Resistance Market Size by Player
3.1 Antiviral Drug Resistance Market Size Market Share by Players
3.1.1 Global Antiviral Drug Resistance Revenue by Players (2020-2022)
3.1.2 Global Antiviral Drug Resistance Revenue Market Share by Players (2020-2022)
3.2 Global Antiviral Drug Resistance Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Antiviral Drug Resistance by Regions
4.1 Antiviral Drug Resistance Market Size by Regions (2017-2022)
4.2 Americas Antiviral Drug Resistance Market Size Growth (2017-2022)
4.3 APAC Antiviral Drug Resistance Market Size Growth (2017-2022)
4.4 Europe Antiviral Drug Resistance Market Size Growth (2017-2022)
4.5 Middle East & Africa Antiviral Drug Resistance Market Size Growth (2017-2022)
5 Americas
5.1 Americas Antiviral Drug Resistance Market Size by Country (2017-2022)
5.2 Americas Antiviral Drug Resistance Market Size by Type (2017-2022)
5.3 Americas Antiviral Drug Resistance Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antiviral Drug Resistance Market Size by Region (2017-2022)
6.2 APAC Antiviral Drug Resistance Market Size by Type (2017-2022)
6.3 APAC Antiviral Drug Resistance Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Antiviral Drug Resistance by Country (2017-2022)
7.2 Europe Antiviral Drug Resistance Market Size by Type (2017-2022)
7.3 Europe Antiviral Drug Resistance Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antiviral Drug Resistance by Region (2017-2022)
8.2 Middle East & Africa Antiviral Drug Resistance Market Size by Type (2017-2022)
8.3 Middle East & Africa Antiviral Drug Resistance Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Antiviral Drug Resistance Market Forecast
10.1 Global Antiviral Drug Resistance Forecast by Regions (2023-2028)
10.1.1 Global Antiviral Drug Resistance Forecast by Regions (2023-2028)
10.1.2 Americas Antiviral Drug Resistance Forecast
10.1.3 APAC Antiviral Drug Resistance Forecast
10.1.4 Europe Antiviral Drug Resistance Forecast
10.1.5 Middle East & Africa Antiviral Drug Resistance Forecast
10.2 Americas Antiviral Drug Resistance Forecast by Country (2023-2028)
10.2.1 United States Antiviral Drug Resistance Market Forecast
10.2.2 Canada Antiviral Drug Resistance Market Forecast
10.2.3 Mexico Antiviral Drug Resistance Market Forecast
10.2.4 Brazil Antiviral Drug Resistance Market Forecast
10.3 APAC Antiviral Drug Resistance Forecast by Region (2023-2028)
10.3.1 China Antiviral Drug Resistance Market Forecast
10.3.2 Japan Antiviral Drug Resistance Market Forecast
10.3.3 Korea Antiviral Drug Resistance Market Forecast
10.3.4 Southeast Asia Antiviral Drug Resistance Market Forecast
10.3.5 India Antiviral Drug Resistance Market Forecast
10.3.6 Australia Antiviral Drug Resistance Market Forecast
10.4 Europe Antiviral Drug Resistance Forecast by Country (2023-2028)
10.4.1 Germany Antiviral Drug Resistance Market Forecast
10.4.2 France Antiviral Drug Resistance Market Forecast
10.4.3 UK Antiviral Drug Resistance Market Forecast
10.4.4 Italy Antiviral Drug Resistance Market Forecast
10.4.5 Russia Antiviral Drug Resistance Market Forecast
10.5 Middle East & Africa Antiviral Drug Resistance Forecast by Region (2023-2028)
10.5.1 Egypt Antiviral Drug Resistance Market Forecast
10.5.2 South Africa Antiviral Drug Resistance Market Forecast
10.5.3 Israel Antiviral Drug Resistance Market Forecast
10.5.4 Turkey Antiviral Drug Resistance Market Forecast
10.5.5 GCC Countries Antiviral Drug Resistance Market Forecast
10.6 Global Antiviral Drug Resistance Forecast by Type (2023-2028)
10.7 Global Antiviral Drug Resistance Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 AccuBioTech Co., Ltd.
11.1.1 AccuBioTech Co., Ltd. Company Information
11.1.2 AccuBioTech Co., Ltd. Antiviral Drug Resistance Product Offered
11.1.3 AccuBioTech Co., Ltd. Antiviral Drug Resistance Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AccuBioTech Co., Ltd. Main Business Overview
11.1.5 AccuBioTech Co., Ltd. Latest Developments
11.2 ACON Laboratories, Inc.
11.2.1 ACON Laboratories, Inc. Company Information
11.2.2 ACON Laboratories, Inc. Antiviral Drug Resistance Product Offered
11.2.3 ACON Laboratories, Inc. Antiviral Drug Resistance Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 ACON Laboratories, Inc. Main Business Overview
11.2.5 ACON Laboratories, Inc. Latest Developments
11.3 Siemens AG
11.3.1 Siemens AG Company Information
11.3.2 Siemens AG Antiviral Drug Resistance Product Offered
11.3.3 Siemens AG Antiviral Drug Resistance Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Siemens AG Main Business Overview
11.3.5 Siemens AG Latest Developments
11.4 BioMerieux SA
11.4.1 BioMerieux SA Company Information
11.4.2 BioMerieux SA Antiviral Drug Resistance Product Offered
11.4.3 BioMerieux SA Antiviral Drug Resistance Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 BioMerieux SA Main Business Overview
11.4.5 BioMerieux SA Latest Developments
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Bio-Rad Laboratories, Inc. Company Information
11.5.2 Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Product Offered
11.5.3 Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.5.5 Bio-Rad Laboratories, Inc. Latest Developments
11.6 Danaher
11.6.1 Danaher Company Information
11.6.2 Danaher Antiviral Drug Resistance Product Offered
11.6.3 Danaher Antiviral Drug Resistance Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Danaher Main Business Overview
11.6.5 Danaher Latest Developments
11.7 Abbott
11.7.1 Abbott Company Information
11.7.2 Abbott Antiviral Drug Resistance Product Offered
11.7.3 Abbott Antiviral Drug Resistance Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Abbott Main Business Overview
11.7.5 Abbott Latest Developments
11.8 BD
11.8.1 BD Company Information
11.8.2 BD Antiviral Drug Resistance Product Offered
11.8.3 BD Antiviral Drug Resistance Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 BD Main Business Overview
11.8.5 BD Latest Developments
11.9 F. Hoffmann-La Roche Ltd.
11.9.1 F. Hoffmann-La Roche Ltd. Company Information
11.9.2 F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Product Offered
11.9.3 F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.9.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.10 Trinity Biotech
11.10.1 Trinity Biotech Company Information
11.10.2 Trinity Biotech Antiviral Drug Resistance Product Offered
11.10.3 Trinity Biotech Antiviral Drug Resistance Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Trinity Biotech Main Business Overview
11.10.5 Trinity Biotech Latest Developments
12 Research Findings and Conclusion
Table 1. Antiviral Drug Resistance Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Immunodiagnostics
Table 3. Major Players of Polymerase Chain Reaction (PCR)
Table 4. Major Players of Next Generation Sequencing (NGS)
Table 5. Major Players of Sanger Sequencing
Table 6. Major Players of Other Technologies
Table 7. Antiviral Drug Resistance Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Antiviral Drug Resistance Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Antiviral Drug Resistance Market Size Market Share by Type (2017-2022)
Table 10. Antiviral Drug Resistance Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Antiviral Drug Resistance Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Antiviral Drug Resistance Market Size Market Share by Application (2017-2022)
Table 13. Global Antiviral Drug Resistance Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Antiviral Drug Resistance Revenue Market Share by Player (2020-2022)
Table 15. Antiviral Drug Resistance Key Players Head office and Products Offered
Table 16. Antiviral Drug Resistance Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Antiviral Drug Resistance Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Antiviral Drug Resistance Market Size Market Share by Regions (2017-2022)
Table 21. Americas Antiviral Drug Resistance Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Antiviral Drug Resistance Market Size Market Share by Country (2017-2022)
Table 23. Americas Antiviral Drug Resistance Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Antiviral Drug Resistance Market Size Market Share by Type (2017-2022)
Table 25. Americas Antiviral Drug Resistance Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Antiviral Drug Resistance Market Size Market Share by Application (2017-2022)
Table 27. APAC Antiviral Drug Resistance Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Antiviral Drug Resistance Market Size Market Share by Region (2017-2022)
Table 29. APAC Antiviral Drug Resistance Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Antiviral Drug Resistance Market Size Market Share by Type (2017-2022)
Table 31. APAC Antiviral Drug Resistance Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Antiviral Drug Resistance Market Size Market Share by Application (2017-2022)
Table 33. Europe Antiviral Drug Resistance Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Antiviral Drug Resistance Market Size Market Share by Country (2017-2022)
Table 35. Europe Antiviral Drug Resistance Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Antiviral Drug Resistance Market Size Market Share by Type (2017-2022)
Table 37. Europe Antiviral Drug Resistance Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Antiviral Drug Resistance Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Antiviral Drug Resistance Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Antiviral Drug Resistance Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Antiviral Drug Resistance Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Antiviral Drug Resistance Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Antiviral Drug Resistance Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Antiviral Drug Resistance Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Antiviral Drug Resistance
Table 46. Key Market Challenges & Risks of Antiviral Drug Resistance
Table 47. Key Industry Trends of Antiviral Drug Resistance
Table 48. Global Antiviral Drug Resistance Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Antiviral Drug Resistance Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Antiviral Drug Resistance Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Antiviral Drug Resistance Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Antiviral Drug Resistance Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Antiviral Drug Resistance Market Size Market Share Forecast by Application (2023-2028)
Table 54. AccuBioTech Co., Ltd. Details, Company Type, Antiviral Drug Resistance Area Served and Its Competitors
Table 55. AccuBioTech Co., Ltd. Antiviral Drug Resistance Product Offered
Table 56. AccuBioTech Co., Ltd. Antiviral Drug Resistance Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. AccuBioTech Co., Ltd. Main Business
Table 58. AccuBioTech Co., Ltd. Latest Developments
Table 59. ACON Laboratories, Inc. Details, Company Type, Antiviral Drug Resistance Area Served and Its Competitors
Table 60. ACON Laboratories, Inc. Antiviral Drug Resistance Product Offered
Table 61. ACON Laboratories, Inc. Main Business
Table 62. ACON Laboratories, Inc. Antiviral Drug Resistance Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. ACON Laboratories, Inc. Latest Developments
Table 64. Siemens AG Details, Company Type, Antiviral Drug Resistance Area Served and Its Competitors
Table 65. Siemens AG Antiviral Drug Resistance Product Offered
Table 66. Siemens AG Main Business
Table 67. Siemens AG Antiviral Drug Resistance Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Siemens AG Latest Developments
Table 69. BioMerieux SA Details, Company Type, Antiviral Drug Resistance Area Served and Its Competitors
Table 70. BioMerieux SA Antiviral Drug Resistance Product Offered
Table 71. BioMerieux SA Main Business
Table 72. BioMerieux SA Antiviral Drug Resistance Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. BioMerieux SA Latest Developments
Table 74. Bio-Rad Laboratories, Inc. Details, Company Type, Antiviral Drug Resistance Area Served and Its Competitors
Table 75. Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Product Offered
Table 76. Bio-Rad Laboratories, Inc. Main Business
Table 77. Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Bio-Rad Laboratories, Inc. Latest Developments
Table 79. Danaher Details, Company Type, Antiviral Drug Resistance Area Served and Its Competitors
Table 80. Danaher Antiviral Drug Resistance Product Offered
Table 81. Danaher Main Business
Table 82. Danaher Antiviral Drug Resistance Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Danaher Latest Developments
Table 84. Abbott Details, Company Type, Antiviral Drug Resistance Area Served and Its Competitors
Table 85. Abbott Antiviral Drug Resistance Product Offered
Table 86. Abbott Main Business
Table 87. Abbott Antiviral Drug Resistance Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Abbott Latest Developments
Table 89. BD Details, Company Type, Antiviral Drug Resistance Area Served and Its Competitors
Table 90. BD Antiviral Drug Resistance Product Offered
Table 91. BD Main Business
Table 92. BD Antiviral Drug Resistance Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. BD Latest Developments
Table 94. F. Hoffmann-La Roche Ltd. Details, Company Type, Antiviral Drug Resistance Area Served and Its Competitors
Table 95. F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Product Offered
Table 96. F. Hoffmann-La Roche Ltd. Main Business
Table 97. F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. F. Hoffmann-La Roche Ltd. Latest Developments
Table 99. Trinity Biotech Details, Company Type, Antiviral Drug Resistance Area Served and Its Competitors
Table 100. Trinity Biotech Antiviral Drug Resistance Product Offered
Table 101. Trinity Biotech Main Business
Table 102. Trinity Biotech Antiviral Drug Resistance Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Trinity Biotech Latest Developments
List of Figures
Figure 1. Antiviral Drug Resistance Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antiviral Drug Resistance Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Antiviral Drug Resistance Market Size Market Share by Type in 2021
Figure 7. Antiviral Drug Resistance in Hospitals & Clinics
Figure 8. Global Antiviral Drug Resistance Market: Hospitals & Clinics (2017-2022) & ($ Millions)
Figure 9. Antiviral Drug Resistance in Pathology or Diagnostic Laboratories
Figure 10. Global Antiviral Drug Resistance Market: Pathology or Diagnostic Laboratories (2017-2022) & ($ Millions)
Figure 11. Antiviral Drug Resistance in Research Institutes
Figure 12. Global Antiviral Drug Resistance Market: Research Institutes (2017-2022) & ($ Millions)
Figure 13. Antiviral Drug Resistance in Others
Figure 14. Global Antiviral Drug Resistance Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Antiviral Drug Resistance Market Size Market Share by Application in 2021
Figure 16. Global Antiviral Drug Resistance Revenue Market Share by Player in 2021
Figure 17. Global Antiviral Drug Resistance Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Antiviral Drug Resistance Market Size 2017-2022 ($ Millions)
Figure 19. APAC Antiviral Drug Resistance Market Size 2017-2022 ($ Millions)
Figure 20. Europe Antiviral Drug Resistance Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Antiviral Drug Resistance Market Size 2017-2022 ($ Millions)
Figure 22. Americas Antiviral Drug Resistance Value Market Share by Country in 2021
Figure 23. Americas Antiviral Drug Resistance Consumption Market Share by Type in 2021
Figure 24. Americas Antiviral Drug Resistance Market Size Market Share by Application in 2021
Figure 25. United States Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Antiviral Drug Resistance Market Size Market Share by Region in 2021
Figure 30. APAC Antiviral Drug Resistance Market Size Market Share by Application in 2021
Figure 31. China Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Antiviral Drug Resistance Market Size Market Share by Country in 2021
Figure 38. Europe Antiviral Drug Resistance Market Size Market Share by Type in 2021
Figure 39. Europe Antiviral Drug Resistance Market Size Market Share by Application in 2021
Figure 40. Germany Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Antiviral Drug Resistance Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Antiviral Drug Resistance Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Antiviral Drug Resistance Market Size Market Share by Application in 2021
Figure 48. Egypt Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Antiviral Drug Resistance Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 54. APAC Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 55. Europe Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 57. United States Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 58. Canada Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 61. China Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 62. Japan Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 63. Korea Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 65. India Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 66. Australia Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 67. Germany Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 68. France Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 69. UK Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 70. Italy Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 71. Russia Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 72. Spain Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 75. Israel Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Antiviral Drug Resistance Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
